Cargando…

The Importance of Tau Phosphorylation for Neurodegenerative Diseases

Fibrillar deposits of highly phosphorylated tau are a key pathological feature of several neurodegenerative tauopathies including Alzheimer’s disease (AD) and some frontotemporal dementias. Increasing evidence suggests that the presence of these end-stage neurofibrillary lesions do not cause neurona...

Descripción completa

Detalles Bibliográficos
Autores principales:	Noble, Wendy, Hanger, Diane P., Miller, Christopher C. J., Lovestone, Simon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2013
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3696910/ https://www.ncbi.nlm.nih.gov/pubmed/23847585 http://dx.doi.org/10.3389/fneur.2013.00083

Ejemplares similares

Functional Implications of Glycogen Synthase Kinase-3-Mediated Tau Phosphorylation
por: Hanger, Diane P., et al.
Publicado: (2011)

Critical residues involved in tau binding to fyn: implications for tau phosphorylation in Alzheimer’s disease
por: Lau, Dawn H. W., et al.
Publicado: (2016)

Roles of tau protein in health and disease
por: Guo, Tong, et al.
Publicado: (2017)

Tau phosphorylation affects its axonal transport and degradation
por: Rodríguez-Martín, Teresa, et al.
Publicado: (2013)

Astrocytes are important mediators of Aβ-induced neurotoxicity and tau phosphorylation in primary culture
por: Garwood, C J, et al.
Publicado: (2011)

Editorial: Tau Propagation Mechanisms: Cell Models, Animal Models, and Beyond
por: Motoi, Yumiko, et al.
Publicado: (2020)

A new TAO kinase inhibitor reduces tau phosphorylation at sites associated with neurodegeneration in human tauopathies
por: Giacomini, Caterina, et al.
Publicado: (2018)

Inhibition of glycogen synthase kinase-3 by BTA-EG(4) reduces tau abnormalities in an organotypic brain slice culture model of Alzheimer’s disease
por: Croft, Cara L., et al.
Publicado: (2017)

Upregulation of calpain activity precedes tau phosphorylation and loss of synaptic proteins in Alzheimer’s disease brain
por: Kurbatskaya, Ksenia, et al.
Publicado: (2016)

Physiological release of endogenous tau is stimulated by neuronal activity
por: Pooler, Amy M, et al.
Publicado: (2013)

The microtubule-associated protein tau is phosphorylated by Syk
por: Lebouvier, Thibaud, et al.
Publicado: (2008)

A pathogenic tau fragment compromises microtubules, disrupts insulin signaling and induces the unfolded protein response
por: Guo, Tong, et al.
Publicado: (2019)

Modification of the Drosophila model of in vivo Tau toxicity reveals protective phosphorylation by GSK3β
por: Povellato, Giulia, et al.
Publicado: (2013)

The Evolution of Tau Phosphorylation and Interactions
por: Trushina, Nataliya I., et al.
Publicado: (2019)

Targeting Prion-like Cis Phosphorylated Tau Pathology in Neurodegenerative Diseases
por: Albayram, Onder, et al.
Publicado: (2018)

Relevance of Phosphorylation and Truncation of Tau to the Etiopathogenesis of Alzheimer’s Disease
por: Zhou, Yan, et al.
Publicado: (2018)

Novel Functions of the Neurodegenerative-Related Gene Tau in Cancer
por: Gargini, Ricardo, et al.
Publicado: (2019)

Tau expression and phosphorylation in enteroendocrine cells
por: Chapelet, Guillaume, et al.
Publicado: (2023)

Structural Basis of Tau Interaction With BIN1 and Regulation by Tau Phosphorylation
por: Lasorsa, Alessia, et al.
Publicado: (2018)

Tau imaging in neurodegenerative diseases
por: Dani, M., et al.
Publicado: (2015)

p53 is upregulated in Alzheimer's disease and induces tau phosphorylation in HEK293a cells
por: Hooper, Claudie, et al.
Publicado: (2007)

Integrated (18)F-T807 Tau PET, Structural MRI, and Plasma Tau in Tauopathy Neurodegenerative Disorders
por: Li, Cheng-Hsuan, et al.
Publicado: (2021)

Bridging integrator 1 protein loss in Alzheimer’s disease promotes synaptic tau accumulation and disrupts tau release
por: Glennon, Elizabeth B, et al.
Publicado: (2020)

Physiological and pathological phosphorylation of tau by Cdk5
por: Kimura, Taeko, et al.
Publicado: (2014)

AMI, an Indazole Derivative, Improves Parkinson’s Disease by Inhibiting Tau Phosphorylation
por: Mao, Zhang, et al.
Publicado: (2020)

Constant Levels of Tau Phosphorylation in the Brain of htau Mice
por: Neddens, Joerg, et al.
Publicado: (2020)

The Role of MicroRNAs in Aβ Deposition and Tau Phosphorylation in Alzheimer’s Disease
por: Zhao, Juanjuan, et al.
Publicado: (2017)

It takes more than tau to tangle: using proteomics to determine how phosphorylated tau mediates toxicity in neurodegenerative diseases
por: Pires, Geoffrey, et al.
Publicado: (2021)

The ER-Mitochondria Tethering Complex VAPB-PTPIP51 Regulates Autophagy
por: Gomez-Suaga, Patricia, et al.
Publicado: (2017)

Tau Phosphorylation in a Mouse Model of Temporal Lobe Epilepsy
por: Alves, Marianna, et al.
Publicado: (2019)

Deletion of Crry, the murine ortholog of the sporadic Alzheimer's disease risk gene CR1, impacts tau phosphorylation and brain CFH
por: Killick, R., et al.
Publicado: (2013)

Labeling Pathological Tau: An Important Quest for the Unknown
por: Vega, Irving E.
Publicado: (2016)

Membrane association and release of wild-type and pathological tau from organotypic brain slice cultures
por: Croft, Cara L, et al.
Publicado: (2017)

Reversible Tau Phosphorylation Induced by Synthetic Torpor in the Spinal Cord of the Rat
por: Hitrec, Timna, et al.
Publicado: (2021)

Sphingolipids in neurodegenerative diseases
por: Pan, Xueyang, et al.
Publicado: (2023)

Lipid Metabolism Influence on Neurodegenerative Disease Progression: Is the Vehicle as Important as the Cargo?
por: Estes, Raja Elizabeth, et al.
Publicado: (2021)

Granulovacuolar Degenerations Appear in Relation to Hippocampal Phosphorylated Tau Accumulation in Various Neurodegenerative Disorders
por: Yamazaki, Yuu, et al.
Publicado: (2011)

Tauopathy induced by low level expression of a human brain-derived tau fragment in mice is rescued by phenylbutyrate
por: Bondulich, Marie K., et al.
Publicado: (2016)

Phosphorylation of Threonine 175 Tau in the Induction of Tau Pathology in Amyotrophic Lateral Sclerosis—Frontotemporal Spectrum Disorder (ALS-FTSD). A Review
por: Moszczynski, Alexander J., et al.
Publicado: (2018)

Phosphorylated Tau 181 Serum Levels Predict Alzheimer’s Disease in the Preclinical Stage
por: Qin, Wei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_035lr41kthm97c5jrnbn0rp40g